Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
批准号:
7556689
负责人:
Ramesh K. Ganju
金额:
$21.59万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-07-01 至 2010-06-30
关键词:
76-kDa SH2 domain-containing leukocyte proteinAcquired Immunodeficiency SyndromeAntigen ReceptorsApoptosisApoptoticBindingCCR5 geneCD4 Positive T LymphocytesCXCR4 ReceptorsCXCR4 geneCalciumCaspaseCaspase-1Cell MaturationComplexDataDevelopmentDrosophila sli proteinEventHIVHIV Envelope Protein gp120Heat shock proteinsHeat-Shock Proteins 70HomeostasisImmuneImmune System DiseasesKnowledgeLCP2 geneLeadLinkMediatingPTPRC genePathogenesisPathway interactionsPhysiological ProcessesPlayProtein-Serine-Threonine KinasesProto-Oncogene Proteins c-aktRIPK2 geneReceptor SignalingRegulationResearch DesignRoleSignal PathwaySignal TransductionSignaling MoleculeT-Cell ReceptorT-LymphocyteTherapeuticWorkapoptosis in lymphocytesbasechemokinechemokine receptorexpectationforkhead proteininnovationnovelnovel therapeuticsreceptorreceptor functiontherapeutic target
中文摘要
描述(由申请人提供):HIV包膜蛋白gp120在触发T淋巴细胞凋亡中起关键作用,T淋巴细胞凋亡是HIV介导的免疫功能障碍的主要致病特征。T细胞凋亡也是在T细胞的稳态和成熟期间调节抗原受体库选择的生理过程。我们假设gp120诱导的T细胞受体(TCR)和趋化因子受体信号通路之间的串扰导致细胞凋亡。我们关于TCR信号传导组分CD45和SLP-76在HIV-gpl20诱导的细胞凋亡中的作用的初步数据支持这一假设。此外,我们最近发现TCR和趋化因子受体CXCR 4之间的相互作用通过一种新的机制调节细胞凋亡,该机制由AKT/蛋白激酶B(PKB)、热休克蛋白-70(HSP-70)、半胱天冬酶-1和RIP2(含半胱天冬酶募集结构域的丝氨酸/苏氨酸激酶)介导。为了分析TCR组分和趋化因子受体CXCR4/CCR5如何调节gp120诱导的细胞凋亡,我们将追求以下具体目标:目的1)我们将通过定义CD45的结构域和表征负责细胞凋亡的CD45信号传导来评估CD45和CXCR4/CCR5信号传导分子之间的相互作用。目的2)我们将对TCR介导的下游效应子SLP-76进行结构和功能分析,该效应子介导Ca 2+依赖性凋亡途径。目的3)分析AKT/HSP-70凋亡通路中可能导致叉头转录因子诱导的作用,并表征caspase-1的激活及其受RIP2的调节。我们也在探索创新的策略来抑制gp120诱导的细胞凋亡。在这方面,我们已经表明,一种新的蛋白质,Slit,它结合到Robo受体和调节CXCR4功能可以抑制gp120诱导的细胞凋亡。目的4)我们将鉴定Slit/Robo复合物中的哪些结构域调节所观察到的抗凋亡作用。这些研究旨在鉴定参与T细胞损失的凋亡信号分子和效应通路,从而提供新的治疗靶点以对抗艾滋病中的免疫缺陷。
英文摘要
DESCRIPTION (provided by applicant): The HIV-envelope protein gp120 plays a critical role in triggering the apoptosis of T-lymphocytes, which is a central pathogenic feature of HIV-mediated immune dysfunction. T-cell apoptosis is also a physiological process that regulates antigen receptor repertoire selection during homeostasis and the maturation of T- cells. We hypothesize that gp120-induced cross-talk between T-cell receptor (TCR) and chemokine receptor signaling pathways leads to apoptosis. Our preliminary data on the role of the TCR signaling components CD45 and SLP-76 in HIV-gpl20-induced apoptosis support this hypothesis. In addition, we have recently shown that cross-talk between TCR and chemokine receptor CXCR4 regulates apoptosis via a novel mechanism that is mediated by AKT/Protein Kinase B (PKB), heat shock protein-70 (HSP-70), caspase-1 and RIP2 (caspase recruitment domain-containing serine/threonine kinase). To analyze mechanistically how the TCR components and chemokine receptors CXCR4/CCR5 regulate gp120-induced apoptosis, we will pursue the following specific aims: Aim 1) we will assess the interaction between CD45 and CXCR4/CCR5 signaling molecules by defining the domain of CD45 and characterizing the CD45 signaling responsible for apoptosis. Aim 2) we will perform structural and functional analyses of the TCR-mediated downstream effector SLP-76 that mediates Ca2+dependent apoptotic pathways. Aim 3) we will analyze the role of the AKT/HSP-70 apoptotic pathway that may lead to the induction of forkhead transcription factors, and will characterize the activation of caspase-1 and its regulation by RIP2. We are also exploring innovative strategies to inhibit gp120-induced apoptosis. In this regard, we have shown that a novel protein, Slit, which binds to the Robo receptor and modulates CXCR4 function can inhibit gp120-induced apoptosis. Aim 4) we will identify which domains in the Slit/Robo complex regulate the observed anti-apoptotic effects. These studies are designed to identify apoptotic signaling molecules and effector pathways involved in T-cell loss, and thus to provide novel therapeutic targets to combat immune deficiency in AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
-
批准号:9888345
-
项目类别:
-
资助金额:$44.1万
-
财政年份:2019
-
负责人:Ramesh K. Ganju
-
依托单位:
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
-
批准号:10372950
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2019
-
负责人:Ramesh K. Ganju
-
依托单位:
Addressing cancer disparity through defining the molecular link between breast feeding and triple negative breast cancer
-
批准号:10590700
-
项目类别:
-
资助金额:$43.78万
-
财政年份:2019
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8526420
-
项目类别:
-
资助金额:$28.29万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Synthetic cannabinoids as novel therapeutic strategies against non-small cell lun
-
批准号:8294608
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8329625
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8777633
-
项目类别:
-
资助金额:$6.24万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Novel approaches to attenuate lipopolysaccharide-induced inflammation
-
批准号:8291967
-
项目类别:
-
资助金额:$19.06万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8841515
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8113028
-
项目类别:
-
资助金额:$30.1万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of S100A7 in breast cancer progression and metastasis
-
批准号:8699159
-
项目类别:
-
资助金额:$29.19万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Synthetic cannabinoids as novel therapeutic strategies against non-small cell lun
-
批准号:8206385
-
项目类别:
-
资助金额:$19.9万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Novel approaches to attenuate lipopolysaccharide-induced inflammation
-
批准号:8167377
-
项目类别:
-
资助金额:$22.88万
-
财政年份:2011
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
-
批准号:7121406
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2006
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
-
批准号:7492863
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
-
批准号:7633280
-
项目类别:
-
资助金额:$50.06万
-
财政年份:2006
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Chemokine & T-Cell Receptors in HIV Pathogenesis
-
批准号:7253266
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2006
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Slit in CXCR4-Mediated Breast Cancer Metastasis
-
批准号:6921012
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2005
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Slit in CXCR4-Mediated Breast Cancer Metastasis
-
批准号:7668345
-
项目类别:
-
资助金额:$22.47万
-
财政年份:2005
-
负责人:Ramesh K. Ganju
-
依托单位:
Role of Slit in CXCR4-Mediated Breast Cancer Metastasis
-
批准号:7074030
-
项目类别:
-
资助金额:$26.23万
-
财政年份:2005
-
负责人:Ramesh K. Ganju
-
依托单位:
海外基金